India Computed Tomography Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

India Computed Tomography Market Trends and Insights

Escalating Cancer Prevalence & Screening Programs

Nearly 2 million new cancer cases are expected annually by 2040, heightening the need for timely CT-based diagnosis. Standardized pathways from the National Cancer Grid are funneling more patients to imaging centers equipped with 64-slice or higher platforms. Government projects such as MegCan Care are removing cost barriers, lifting examination volume at public hospitals. AI-powered oncology suites introduced at AIIMS Delhi demonstrate how image-analysis algorithms can cut report turnaround time and improve tumor detection accuracy. With oncology already the largest clinical segment inside the India Computed Tomography (CT) market, broader screening protocols are reinforcing equipment replacement cycles in metropolitan hubs before diffusing to tier-2 cities.

Rising Public-Sector Hospital Capex (Ayushman Bharat, State Tenders)

The Pradhan Mantri Ayushman Bharat Health Infrastructure Mission allocates USD 7.7 billion for new and upgraded diagnostic suites across India. Procurement guidelines favor domestically manufactured scanners, accelerating order flow for vendors with PLI-certified plants. Recent installations of 128-slice units in government trauma centers are raising the benchmark for image quality in emergency medicine. Sixteen additional AIIMS campuses, each requiring multi-room imaging departments, promise recurring tenders through the decade. Reimbursement revisions under CGHS, with higher tariffs for accredited facilities, are cushioning operating margins for public hospitals that invest in dose-efficient CT platforms.

Rapid AI/ML Integration for Dose-Optimized Scans & Workflow

India’s healthcare AI market is expanding at 40.6% CAGR, catalyzing upgrades toward scanners that embed real-time image reconstruction and automated protocol selection. GE HealthCare’s TrueFidelity-equipped systems reduce radiation by as much as 80% while preserving spatial resolution, a vital benefit in pediatric and oncology imaging. Partnerships between the National Health Authority and IIT Kanpur are generating open-source models that standardize chest CT interpretation, permitting faster nationwide rollouts. Private hospital chains are leveraging AI dashboards to balance scanner load and boost throughput, further elevating utilization rates across the India Computed Tomography (CT) market.

PLI-Led Domestic CT Manufacturing Push

A dedicated USD 410 million PLI incentive pool for medical imaging has sparked 13 greenfield plants, cutting lead times for mid-slice systems by 30%. Wipro GE Healthcare exported its first “Made in India” PET-CT to 15 countries in 2024, underlining the shift from import substitution to global supply participation. The prohibition on refurbished equipment imports removes a low-cost alternative, channeling demand into newer locally built scanners whose prices are already 30-50% below comparable imports. State tenders now carry 50% domestic value-addition mandates, further strengthening local assembly lines

High Acquisition & Lifecycle Costs of ≥64-Slice Systems

Premium systems can exceed total equipment budgets of mid-sized hospitals, especially where per-bed capital outlay is capped near USD 18,000. Service contracts, tube replacements and software updates often equal 40-60% of the original invoice across a decade. These economics constrain adoption beyond metropolitan centers despite rising clinical demand for cardiac CT angiography. Although domestic manufacturing trims list prices, financing innovations will remain critical for broader penetration of the India Computed Tomography (CT) market.

Shortage of Radiologists / Service Engineers

India’s radiologist density lags global norms, limiting after-hours coverage and undercutting scanner utilization. Skilled service personnel are scarce outside state capitals, extending downtime during tube or detector failures. Remote maintenance modules and predictive analytics are reducing unplanned outages, yet a nationwide service talent pipeline remains essential for sustained performance of the India Computed Tomography (CT) market.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Technology: Mid-Slice Systems Retain Center-Stage

Mid-slice scanners accounted for 42.78% of the India Computed Tomography (CT) market in 2025, confirming their sweet-spot balance between price and performance. Rising cardiology and trauma volumes are prompting tier-1 hospitals to upgrade to 128-slice platforms, which are advancing at 7.08% CAGR through 2031. The India Computed Tomography (CT) market size for 64-slice equipment remains substantial, but share is drifting toward higher arrays as procurement specifications tighten. Vendors are launching AI-ready mid-slice models with iterative reconstruction engines, preserving the segment’s relevance in budget-sensitive districts. Over time, lower total cost of ownership and dual-energy add-ons are expected to accelerate the shift away from <64-slice machines.

Second-generation photon-counting prototypes showcased at AOCR 2025 spotlight long-term innovation pathways, yet commercial uptake will hinge on price curves suitable for the India Computed Tomography (CT) market. Government tenders are also specifying radiation dose caps, giving AI-assisted 128-slice units an edge. Consequently, the technology landscape will feature a gradual laddering effect, with mid-slice as entry point and high-slice as clinical aspiration.

By Product Type: Stationary Systems Dominate While Mobility Gains Pace

Stationary platforms held 88.22% share of the India Computed Tomography (CT) market size in 2025. Their integration with PACS, power infrastructure and shielding makes them the backbone of multispecialty hospitals. Portable scanners, however, are registering the quickest 7.56% CAGR by delivering bedside neuro imaging in intensive-care units. Manufacturers are shrinking gantry footprints and using lithium-ion power packs to suit makeshift isolation wards. Policy efforts to equip disaster-response teams with mobile CT vans are opening a parallel growth track. As trauma protocols mature, dual-duty deployments that swing between emergency departments and operating suites are likely to lift mobility’s contribution inside the India Computed Tomography (CT) market.

Financiers are experimenting with pay-per-day rental contracts for pop-up radiology camps, fostering first-time adoption in remote areas. Yet image-quality limitations and cooling requirements confine mobile units to targeted clinical scenarios. The stationary segment will thus preserve its structural dominance, aided by hospital-bed expansion programs that anchor volume stability.

By Application: Oncology Remains Centerpiece Amid Maxillofacial Upsurge

Oncology represented 42.55% of the India Computed Tomography (CT) market share in 2025, underscoring cancer imaging’s entrenched priority. Lung screening pilots in metro populations are multiplying scan counts, and radiotherapy planning needs precise 3D datasets. Dental and maxillofacial imaging is the fastest-growing application at 7.36% CAGR, fueled by cosmetic dentistry and implant workflows in urban clinics. AI-enabled nodule detection aids pulmonology, while improved reconstruction speeds favor rapid trauma triage.

Cardiac CT angiography volumes are climbing after NABH standardized accreditation criteria, making calcium scoring routine before elective interventions. Orthopedic practices are adopting low-dose protocols for pre-surgical planning, broadening the India Computed Tomography (CT) market size across musculoskeletal use-cases. Growth in neurology stems from decentralized stroke centers that require perfusion CT capability. Collectively, these shifts sustain multi-slice adoption and diversify revenue streams beyond core oncology usage.

By End-User: Hospitals Anchor Sales While Outpatient Hubs Accelerate

Hospitals generated 61.12% of India Computed Tomography (CT) market revenue in 2025, supported by new AIIMS campuses and multi-hospital private chains. Bed additions across tier-2 cities guarantee baseline scanner demand over the forecast window. Ambulatory surgical centers lead growth at 7.05% CAGR as insurers incentivize day-care procedures. Radiology chains are scaling hub-and-spoke models, pooling CT referrals from satellite clinics through shared PACS.

Academic institutes capture research grants for AI model training, buying high-slice systems with dual-energy options. Veterinary and dental clinics represent smaller but noticeably rising pockets in the India Computed Tomography (CT) market, propelled by higher pet ownership and premium oral-care demand. Flexible financing, combined with modular upgrade paths, is lowering ownership thresholds for these niche buyers.

By Device Architecture: Spiral Systems Hold Ground, C-Arm Spurs Hybrid Suites

Spiral scanners controlled 81.35% of the India Computed Tomography (CT) market in 2025. Continuous helical acquisition supports routine thorax-to-pelvis protocols and contrast-enhanced studies. C-arm CT is advancing at 7.22% CAGR, propelled by hybrid operating rooms that integrate imaging with angiographic guidance. Neurosurgical teams prefer O-arm configurations for intra-operative spine navigation, a trend still nascent but visible.

Flat-panel detector CT finds niche use in orthopedic clinics for weight-bearing extremity exams. Ring-gantry devices anchored to radiotherapy systems remain steady in large oncology centers. The India Computed Tomography (CT) market size for spiral systems will continue to dwarf other architectures, yet cross-disciplinary procedures are ensuring incremental share gains for C-arm platforms.

Geography Analysis

Northern and western metros dominate revenue owing to dense hospital networks and higher per-capita spending. Delhi-NCR and Mumbai cumulatively host more than 600 CT rooms, many equipped with ≥128-slice scanners for advanced cardiology. Southern metros such as Bengaluru and Chennai form the manufacturing and R&D nucleus, partly because Karnataka’s PLI incentives attract multinational assembly lines. State investments in Kalyani and Mangalagiri AIIMS are leveling regional access, routing procurement to eastern and southern corridors.

Tier-2 and tier-3 cities contribute a rising share of India Computed Tomography (CT) market volume as 40 million residents shift to urban clusters by FY27. Setup costs that are 90% below metro benchmarks let operators achieve faster breakeven, sparking chain-clinic proliferation. Revised CGHS rules mandating specialist referral for scans over INR 3,000 are fostering standardized imaging pathways from district hospitals to private centers, spurring equipment deployments.

Rural belts are beginning to see mobile scanner rollouts funded by disaster management agencies and CSR foundations. BharatNet’s fiber network backhaul permits teleradiology services that offset radiologist scarcity. Centralized equipment grants within the Ayushman Bharat mission are expected to place low-slice units in 150 community health centers by 2027, cementing a long-tail demand pipeline for the India Computed Tomography (CT) market.

Regulatory Landscape

CT scanners in India are regulated as medical devices under the Drugs and Cosmetics Act, 1940 and the Medical Devices Rules, 2017 (MDR 2017). CT scanner equipment was brought explicitly under the Drugs and Cosmetics Act framework effective April 1, 2021, which makes licensing, registration, and compliance obligations applicable to manufacturers and importers.

The Central Drugs Standard Control Organisation (CDSCO), as the Central Licensing Authority, oversees device registration and import licensing. In parallel, market conduct and competitive dynamics are being scrutinized through policy work such as the Competition Commission of India (CCI) market study (2024) on diagnostic medical imaging equipment. On the operating side, radiation-safety approvals and facility readiness remain an execution gate for new installations, so compliant site planning and documentation must run alongside device-level regulatory clearances.

Value Chain Analysis

The India CT scanner value chain includes global component suppliers (detectors, tubes, scintillators and electronics), OEM platform design and manufacturing/assembly, authorized importers and distributors, and downstream site planners and shielding contractors. Downstream operators include hospitals and diagnostic imaging centers. Historically, the value chain has been import-dependent, and the CCI (2024) notes that a large share of diagnostic medical imaging equipment in India is imported, linking system availability and pricing to foreign supply lead times and currency movements.

PLI-led localization is shifting the midstream as major OEMs increase local assembly/production and build service infrastructure in hubs such as Bengaluru, Pune, and Chennai. This improves parts positioning and reduces downtime risk for operators. At the same time, critical components remain largely sourced internationally, leaving residual exposure to component availability and logistics, which keeps after-sales service networks, preventive maintenance, and local spare-part stocking central to how hospitals and imaging chains evaluate total lifecycle cost.

Market Opportunities and Future Outlook

Public and private procurement is creating whitespace in tier-2 and tier-3 catchments where access constraints are increasingly addressed through Ayushman Bharat-linked utilization and expanding diagnostic infrastructure. The Pradhan Mantri Ayushman Bharat Health Infrastructure Mission allocation (USD 7.7 billion) supports creation and upgrades of diagnostic suites, while tender preferences for domestically manufactured scanners are steering demand toward locally assembled mid-slice and high-slice configurations that meet domestic value-addition requirements.

Technology-led opportunity is tightening around workflow and dose governance, where AI-enabled reconstruction and protocoling improve throughput for radiology departments constrained by staffing. Clinical partnerships are also influencing premium adoption pathways, including Philips working with ACTREC and Tata Memorial Centre on Spectral CT for earlier cancer detection (Feb 2026), and AI-integrated innovation programs such as the AIIMS and Wipro GE Healthcare collaboration (Dec 2024) aimed at deployment-ready imaging intelligence. With refurbished imports restricted and OEMs expanding India-based manufacturing footprints, operators are comparing upgradeable new systems bundled with service, training, and digital workflow integration rather than relying on older secondary-market supply.